Artiva Biotherapeutics (ARTV) Gains from Sales and Divestitures (2024 - 2026)
Artiva Biotherapeutics (ARTV) reported Gains from Sales and Divestitures of $108976.0 for Q1 2026, down 61.45% quarter-over-quarter from $282687.0 in Q4 2025.
Artiva Biotherapeutics (ARTV) Gains from Sales and Divestitures (2024 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 3 years of Gains from Sales and Divestitures data on file, last reported at $108976.0 in Q1 2026.
- Gains from Sales and Divestitures for Q1 2026 came in at $108976.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $108976.0 (changed N/A YoY), and the FY2025 annual result was $282687.0, up 1155.61% from the prior year.
- Gains from Sales and Divestitures retreated to $108976.0 in Q1 2026 per ARTV's latest filing, from $282687.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $282687.0 in Q4 2025 and troughed at $22514.0 in Q4 2024.
- A 3-year average of $133586.8 and a median of $108976.0 in 2026 frame the typical range for Gains from Sales and Divestitures.
- On a YoY basis, Gains from Sales and Divestitures climbed as much as 1155.61% in 2025 and fell as far as 1155.61% in 2025.
- A 3-year view of Gains from Sales and Divestitures shows it stood at $22514.0 in 2024, then soared by 1155.61% to $282687.0 in 2025, then slumped by 61.45% to $108976.0 in 2026.
- Business Quant data shows ARTV's Gains from Sales and Divestitures at $108976.0 in Q1 2026, $282687.0 in Q4 2025, and $205360.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Artiva Biotherapeutics | 241.85 Mn | 241.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,976.00 |
| Mar 31, 2026 | 108,976.00 |
| Dec 31, 2025 | 282,687.00 |
| Dec 31, 2025 | 282,687.00 |
| Sep 30, 2025 | 205,360.00 |
| Sep 30, 2025 | 205,360.00 |
| Jun 30, 2025 | 48,397.00 |
| Jun 30, 2025 | 48,397.00 |
| Dec 31, 2024 | 22,514.00 |
| Dec 31, 2024 | 22,514.00 |